This site is intended for healthcare professionals only
LoginRegister
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaIT security incident to hurt revenue of few businesses of Sun Pharma
USFDA issues 3 observations for Zydus Lifesciences Ahmedabad facilityUSFDA issues 3 observations for Zydus Lifesciences Ahmedabad facility
Lupin Nagpur facility completes USFDA inspectionLupin successfully completes UK MHRA inspection at Pithampur facilities
Zydus Lifesciences recalls over 55000 bottles of gout drug Colchicine in USZydus Lifesciences recalls over 55000 bottles of gout drug Colchicine in US
USFDA okays Lupin Valbenazine Capsules to treat DyskinesiaUSFDA okays Lupin Valbenazine Capsules to treat Dyskinesia
Emcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug DoravirineEmcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug Doravirine
Syngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panelSyngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panel
Revenue of private hospitals to grow 10-11 percent in financial year 2022-23, 2023-24: ReportRevenue of private hospitals to grow 10-11 percent in financial year 2022-23, 2023-24: Report
Bayer to shift drug research focus away from womens healthBayer to shift drug research focus away from women's health
Moderna, Generation Bio ink pact to develop non-viral genetic medicinesModerna, Generation Bio ink pact to develop non-viral genetic medicines
AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitorAstraZeneca Calquence gets conditional nod in China for adults with previously treated mantle cell...
AstraZeneca to Invest USD 15 Billion in China by 2030All SAEs including death should be reported: CDSCO Panel tells AstraZeneca about Durvalumab
X